Elicio Therapeutics Statistics
Total Valuation
ELTX has a market cap or net worth of $52.54 million. The enterprise value is $52.60 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ELTX has 10.76 million shares outstanding. The number of shares has increased by 896.37% in one year.
| Current Share Class | 10.76M |
| Shares Outstanding | 10.76M |
| Shares Change (YoY) | +896.37% |
| Shares Change (QoQ) | +9.84% |
| Owned by Insiders (%) | 19.80% |
| Owned by Institutions (%) | 9.99% |
| Float | 8.43M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | n/a |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 0.88
| Current Ratio | 0.88 |
| Quick Ratio | 0.46 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -469.64 |
Financial Efficiency
Return on equity (ROE) is -353.02% and return on invested capital (ROIC) is -144.59%.
| Return on Equity (ROE) | -353.02% |
| Return on Assets (ROA) | -96.80% |
| Return on Capital (ROIC) | -144.59% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.21M |
| Employee Count | 32 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.42% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -28.42% |
| 50-Day Moving Average | 4.55 |
| 200-Day Moving Average | 5.82 |
| Relative Strength Index (RSI) | 51.31 |
| Average Volume (20 Days) | 17,692 |
Short Selling Information
The latest short interest is 39,918, so 0.37% of the outstanding shares have been sold short.
| Short Interest | 39,918 |
| Short Previous Month | 39,357 |
| Short % of Shares Out | 0.37% |
| Short % of Float | 0.47% |
| Short Ratio (days to cover) | 2.57 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -41.33M |
| Pretax Income | -38.99M |
| Net Income | -38.67M |
| EBITDA | -41.00M |
| EBIT | -41.33M |
| Earnings Per Share (EPS) | -$4.01 |
Full Income StatementBalance Sheet
The company has $3.43 million in cash and $6.42 million in debt, giving a net cash position of -$2.99 million or -$0.28 per share.
| Cash & Cash Equivalents | 3.43M |
| Total Debt | 6.42M |
| Net Cash | -2.99M |
| Net Cash Per Share | -$0.28 |
| Equity (Book Value) | -1.65M |
| Book Value Per Share | -0.16 |
| Working Capital | -896,000 |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$36.13 million and capital expenditures -$87,000, giving a free cash flow of -$36.22 million.
| Operating Cash Flow | -36.13M |
| Capital Expenditures | -87,000 |
| Free Cash Flow | -36.22M |
| FCF Per Share | -$3.37 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |